{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:37:25Z","timestamp":1770835045207,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione e del Merito","doi-asserted-by":"publisher","award":["cod. CINECA 202254FLSB, CUP: E53D23001220006"],"award-info":[{"award-number":["cod. CINECA 202254FLSB, CUP: E53D23001220006"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione e del Merito","doi-asserted-by":"publisher","award":["cod 2022FN7ANE, CUP E53D23001300006"],"award-info":[{"award-number":["cod 2022FN7ANE, CUP E53D23001300006"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 di Catania","doi-asserted-by":"publisher","award":["programma ricerca di ateneo UNICT 2020-22 linea 2 cod MICROCOSM"],"award-info":[{"award-number":["programma ricerca di ateneo UNICT 2020-22 linea 2 cod MICROCOSM"]}],"id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 di Catania","doi-asserted-by":"publisher","award":["programma ricerca di ateneo UNICT 2020-22 linea 2 cod MICROCOSM"],"award-info":[{"award-number":["programma ricerca di ateneo UNICT 2020-22 linea 2 cod MICROCOSM"]}],"id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 di Catania","doi-asserted-by":"publisher","award":["programma ricerca di ateneo UNICT 2020-22 linea 2 cod MICROCOSM"],"award-info":[{"award-number":["programma ricerca di ateneo UNICT 2020-22 linea 2 cod MICROCOSM"]}],"id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In both chronic lymphatic leukemia (CLL) and follicular lymphoma (FL) immunotherapy determines B-depletion that leads to temporary suppression of humoral immunity, which is clinically relevant especially during the COVID-19 pandemic, when most patients in the first wave received the BNT162b2 vaccine during anti-neoplastic treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To capture changes in the immunome and microbiome composition in CLL and FL patients upon mRNA-based vaccination, we designed a prospective, longitudinal study to profile both the humoral and the cellular response after exposure to the BNT162b2 COVID-19 vaccine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In both CLL patients and FL patients, the second and third administrations of the BNT162b2 vaccine increased the titer of specific antibodies against SARS-CoV-2. In FL patients, vaccination induced expansion of central memory CD8\u2009+\u2009CD57dim CD279\u2009+\u2009T cells and reduction of the neutrophil subset myeloid 1 (CD14<jats:sup>\u2212<\/jats:sup>CD15<jats:sup>+<\/jats:sup>CD16<jats:sup>dim<\/jats:sup>CD64<jats:sup>+<\/jats:sup>CD33<jats:sup>\u2212<\/jats:sup>CD38<jats:sup>+<\/jats:sup>PDL1<jats:sup>+<\/jats:sup>HLA-DR<jats:sup>\u2212<\/jats:sup>); in both cohorts, CD45RA\u2009+\u2009CD27\u2009+\u2009CD279\u2009+\u2009NK cells were expanded after a full cycle of vaccination. After vaccination, the genera Collinsella, Gemmiger, Lachnospiraceae, Blautia, Ruminococcus and Lactobacillus increased in both CLL patients and FL patients, whereas Faecalibacterium, Enterobacteriacae, and Enterococcus decreased. Multivariate analysis failed to identify factors associated with changes in microbiome communities among the CLL and FL cohorts, considering age, sex, exposure to anti-CD20 therapy and disease activity. Only in FL patients, alpha diversity was negatively correlated with neutrophil subsets myeloid 1 e 5 at baseline and positively correlated with neutrophil subset 6 after vaccination. PICRUSt2 analysis showed how microbiome can also affect the host health promoting chronic inflammation. The L-lysine biosynthesis pathway was more represented in CLL patients, whereas the L-valine degradation pathway and the anaerobic degradation of purine nucleobases were overrepresented in the FL cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Taken together, our findings reveal the effect of the BNT162b2 vaccine in shaping the microbiome composition in CLL and FL patients, despite receiving treatment for their underlying active disease, and highlight the importance of a comprehensive analysis of the immunome and microbiome profiling to understand immune function in these cohorts of patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40364-025-00734-w","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:18:11Z","timestamp":1739189891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia"],"prefix":"10.1186","volume":"13","author":[{"given":"Annalisa","family":"Chiarenza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia Vertillo","family":"Aluisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunziatina Laura","family":"Parrinello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Corsale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grete Francesca","family":"Privitera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MojtabaShekarkar","family":"Azgomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"La Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cambria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Curtopelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Isola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cirino","family":"Botta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Santagati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"734_CR1","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Farina F, Weinbergerov\u00e1 B, Itri F, D\u00e1vila-Valls J, Mart\u00edn-P\u00e9rez S, Glenth\u00f8j A, Hersby DS, Gomes da Silva M et al: Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. EClinicalMedicine 2024;71:102553."},{"issue":"1","key":"734_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/hon.3092","volume":"41","author":"M Merli","year":"2023","unstructured":"Merli M, Ferrarini I, Merli F, Busca A, Mina R, Falini B, Bruna R, Cairoli R, Marchetti M, Romano A, et al. SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. Hematol Oncol. 2023;41(1):128\u201338.","journal-title":"Hematol Oncol"},{"issue":"1","key":"734_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hon.3086","volume":"41","author":"F Passamonti","year":"2023","unstructured":"Passamonti F, Nicastri E, Di Rocco A, Guarini A, Ibatici A, Luminari S, Mikulska M, Visco C. Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations. Hematol Oncol. 2023;41(1):3\u201315.","journal-title":"Hematol Oncol"},{"issue":"3","key":"734_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bjh.17704","volume":"195","author":"F Passamonti","year":"2021","unstructured":"Passamonti F, Romano A, Salvini M, Merli F, Porta MGD, Bruna R, Coviello E, Romano I, Cairoli R, Lemoli R, et al. COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. Br J Haematol. 2021;195(3):371\u20137.","journal-title":"Br J Haematol"},{"issue":"7","key":"734_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41408-021-00521-4","volume":"11","author":"P Mondello","year":"2021","unstructured":"Mondello P, Fama A, Larson MC, Feldman AL, Villasboas JC, Yang ZZ, Galkin I, Svelolkin V, Postovalova E, Bagaev A, et al. Lack of intrafollicular memory CD4 +T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood Cancer J. 2021;11(7):130.","journal-title":"Blood Cancer J"},{"issue":"4","key":"734_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002189","volume":"9","author":"N Bozorgmehr","year":"2021","unstructured":"Bozorgmehr N, Okoye I, Oyegbami O, Xu L, Fontaine A, Cox-Kennett N, Larratt LM, Hnatiuk M, Fagarasanu A, Brandwein J, et al. Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia. J Immunother Cancer. 2021;9(4): e002189.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"734_CR7","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1038\/s41467-022-34657-z","volume":"13","author":"LB Cook","year":"2022","unstructured":"Cook LB, O\u2019Dell G, Vourvou E, Palanicawandar R, Marks S, Milojkovic D, Apperley JF, Loaiza S, Claudiani S, Bua M, et al. Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies. Nat Commun. 2022;13(1):6922.","journal-title":"Nat Commun"},{"issue":"2","key":"734_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.seminhematol.2024.01.003","volume":"61","author":"ER Francis","year":"2024","unstructured":"Francis ER, Vu J, Perez CO, Sun C. Vaccinations in patients with chronic lymphocytic leukemia. Semin Hematol. 2024;61(2):131\u20138.","journal-title":"Semin Hematol"},{"issue":"9","key":"734_CR9","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/s41375-023-01938-5","volume":"37","author":"S Cesaro","year":"2023","unstructured":"Cesaro S, Mikulska M, Hirsch HH, Styczynski J, Meylan S, Cordonnier C, Navarro D, von Lilienfeld-Toal M, Mehra V, Marchesi F, et al. Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2023;37(9):1933\u20138.","journal-title":"Leukemia."},{"issue":"5","key":"734_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41408-022-00684-8","volume":"12","author":"V Piechotta","year":"2022","unstructured":"Piechotta V, Mellinghoff SC, Hirsch C, Brinkmann A, Iannizzi C, Kreuzberger N, Adams A, Monsef I, Stemler J, Cornely OA, et al. Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review. Blood Cancer J. 2022;12(5):86.","journal-title":"Blood Cancer J"},{"issue":"1","key":"734_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41467-022-28578-0","volume":"13","author":"D Re","year":"2022","unstructured":"Re D, Seitz-Polski B, Brglez V, Carles M, Gra\u00e7a D, Benzaken S, Liguori S, Zahreddine K, Delforge M, Bailly- Maitre B, et al. Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies. Nat Commun. 2022;13(1):864.","journal-title":"Nat Commun"},{"issue":"1","key":"734_CR12","doi-asserted-by":"publisher","first-page":"2233146","DOI":"10.1080\/19490976.2023.2233146","volume":"15","author":"M Hong","year":"2023","unstructured":"Hong M, Lan T, Li Q, Li B, Yuan Y, Xu F, Wang W. A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines. Gut Microbes. 2023;15(1):2233146.","journal-title":"Gut Microbes"},{"key":"734_CR13","doi-asserted-by":"publisher","first-page":"1157610","DOI":"10.3389\/fonc.2023.1157610","volume":"13","author":"A Duminuco","year":"2023","unstructured":"Duminuco A, Romano A, Leotta D, La Spina E, Cambria D, Bulla A, Del Fabro V, Tibullo D, Giallongo C, Palumbo GA, et al. Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab\/cilgavimab. Front Oncol. 2023;13:1157610.","journal-title":"Front Oncol"},{"key":"734_CR14","doi-asserted-by":"publisher","first-page":"1117815","DOI":"10.3389\/fonc.2023.1117815","volume":"13","author":"GA Palumbo","year":"2023","unstructured":"Palumbo GA, Cambria D, La Spina E, Duminuco A, Laneri A, Longo A, Vetro C, Giallongo S, Romano A, Di Raimondo F, et al. Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID- 19 vaccine. Front Oncol. 2023;13:1117815.","journal-title":"Front Oncol"},{"issue":"2","key":"734_CR15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/bloodadvances.2021005198","volume":"6","author":"C Botta","year":"2022","unstructured":"Botta C, Maia C, Garc\u00e9s JJ, Termini R, Perez C, Manrique I, Burgos L, Zabaleta A, Alignani D, Sarvide S, et al. FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology. Blood Adv. 2022;6(2):690\u2013703.","journal-title":"Blood Adv"},{"issue":"1","key":"734_CR16","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1038\/s41467-023-41562-6","volume":"14","author":"C Botta","year":"2023","unstructured":"Botta C, Perez C, Larrayoz M, Puig N, Cedena MT, Termini R, Goicoechea I, Rodriguez S, Zabaleta A, Lopez A, et al. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nat Commun. 2023;14(1):5825.","journal-title":"Nat Commun"},{"issue":"1","key":"734_CR17","doi-asserted-by":"publisher","first-page":"7237","DOI":"10.1038\/s41598-022-11157-0","volume":"12","author":"A Romano","year":"2022","unstructured":"Romano A, Parrinello NL, Barchitta M, Manuele R, Puglisi F, Maugeri A, Barbato A, Triolo AM, Giallongo C, Tibullo D, et al. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection. Sci Rep. 2022;12(1):7237.","journal-title":"Sci Rep"},{"issue":"17","key":"734_CR18","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.3390\/ijms21176203","volume":"21","author":"M Ragusa","year":"2020","unstructured":"Ragusa M, Santagati M, Mirabella F, Lauretta G, Cirnigliaro M, Brex D, Barbagallo C, Domini CN, Gulisano M, Barone R, et al. Potential Associations Among Alteration of Salivary miRNAs, Saliva Microbiome Structure, and Cognitive Impairments in Autistic Children. Int J Mol Sci. 2020;21(17):6203.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"734_CR19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"734_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nmeth.2276","volume":"10","author":"NA Bokulich","year":"2013","unstructured":"Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, Mills DA, Caporaso JG. Quality- filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10(1):57\u20139.","journal-title":"Nat Methods"},{"issue":"12","key":"734_CR21","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/nmeth.2658","volume":"10","author":"JN Paulson","year":"2013","unstructured":"Paulson JN, Stine OC, Bravo HC, Pop M. Differential abundance analysis for microbial marker-gene surveys. Nat Methods. 2013;10(12):1200\u20132.","journal-title":"Nat Methods"},{"issue":"7","key":"734_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"734_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685\u20138.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"734_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000839","volume":"7","author":"N Yekutiel","year":"2023","unstructured":"Yekutiel N, Chodick G, Tene L, Bronstein Y, Grunspan M, Rivlin N, Ofek K, Cohen R, Raskin L, Komlosi V, et al. COVID-19 breakthrough infections in vaccinated patients with CLL in Israel. Hemasphere. 2023;7(2): e839.","journal-title":"Hemasphere"},{"issue":"27","key":"734_CR25","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"23","key":"734_CR26","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood.2021011568","volume":"137","author":"Y Herishanu","year":"2021","unstructured":"Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, Morales M, Ziv T, Shorer Arbel Y, Scarf\u00f2 L, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137(23):3165\u201373.","journal-title":"Blood"},{"issue":"5","key":"734_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood.2021014085","volume":"139","author":"Y Herishanu","year":"2022","unstructured":"Herishanu Y, Rahav G, Levi S, Braester A, Itchaki G, Bairey O, Dally N, Shvidel L, Ziv-Baran T, Polliack A, et al. Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination. Blood. 2022;139(5):678\u201385.","journal-title":"Blood"},{"issue":"1","key":"734_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hon.3077","volume":"41","author":"S Fiorcari","year":"2023","unstructured":"Fiorcari S, Atene CG, Maffei R, Mesini N, Debbia G, Colasante C, Pozzi S, Barbieri E, Maccaferri M, Leonardi G, et al. Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia. Hematol Oncol. 2023;41(1):120\u20137.","journal-title":"Hematol Oncol"},{"issue":"1","key":"734_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajh.26619","volume":"98","author":"B Beaton","year":"2023","unstructured":"Beaton B, Sasson SC, Rankin K, Raedemaeker J, Wong A, Hastak P, Phetsouphanh C, Warden A, Klemm V, Munier CML, et al. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses. Am J Hematol. 2023;98(1):131\u20139.","journal-title":"Am J Hematol"},{"issue":"9","key":"734_CR30","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3324\/haematol.2021.280455","volume":"107","author":"T Faitov\u00e1","year":"2022","unstructured":"Faitov\u00e1 T, Svanberg R, Da Cunha-Bang C, Ilett EE, J\u00f8rgensen M, Noguera-Julian M, Paredes R, MacPherson CR, Niemann CU. The gut microbiome in patients with chronic lymphocytic leukemia. Haematologica. 2022;107(9):2238\u201343.","journal-title":"Haematologica"},{"issue":"10","key":"734_CR31","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.3324\/haematol.2023.284693","volume":"109","author":"T Faitova","year":"2024","unstructured":"Faitova T, Coelho M, Da Cunha-Bang C, Ozturk S, Kartal E, Bork P, Seiffert M, Niemann CU. The diversity of the microbiome impacts chronic lymphocytic leukemia development in mice and humans. Haematologica. 2024;109(10):3237\u201350.","journal-title":"Haematologica"},{"issue":"6","key":"734_CR32","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/gutjnl-2021-326563","volume":"71","author":"SC Ng","year":"2022","unstructured":"Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, Ching JY, Liu Y, Yan S, Chan DLS, et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut. 2022;71(6):1106\u201316.","journal-title":"Gut"},{"issue":"4","key":"734_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1128\/aem.32.4.623-632.1976","volume":"32","author":"JP Salanitro","year":"1976","unstructured":"Salanitro JP, Muirhead PA, Goodman JR. Morphological and physiological characteristics of Gemmiger formicilis isolated from chicken ceca. Appl Environ Microbiol. 1976;32(4):623\u201332.","journal-title":"Appl Environ Microbiol"},{"key":"734_CR34","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.2147\/JIR.S300989","volume":"14","author":"MT Siddiqui","year":"2021","unstructured":"Siddiqui MT, Cresci GAM. The immunomodulatory functions of butyrate. J Inflamm Res. 2021;14:6025\u201341.","journal-title":"J Inflamm Res"},{"issue":"1","key":"734_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/1462-2920.14454","volume":"21","author":"JA Laverde Gomez","year":"2019","unstructured":"Laverde Gomez JA, Mukhopadhya I, Duncan SH, Louis P, Shaw S, Collie-Duguid E, Crost E, Juge N, Flint HJ. Formate cross-feeding and cooperative metabolic interactions revealed by transcriptomics in co- cultures of acetogenic and amylolytic human colonic bacteria. Environ Microbiol. 2019;21(1):259\u201371.","journal-title":"Environ Microbiol"},{"issue":"5","key":"734_CR36","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1182\/bloodadvances.2020003129","volume":"5","author":"CS Diefenbach","year":"2021","unstructured":"Diefenbach CS, Peters BA, Li H, Raphael B, Moskovits T, Hymes K, Schluter J, Chen J, Bennani NN, Witzig TE, et al. Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B- cell non-Hodgkin lymphoma. Blood Adv. 2021;5(5):1194\u20138.","journal-title":"Blood Adv"},{"key":"734_CR37","doi-asserted-by":"publisher","first-page":"1397485","DOI":"10.3389\/fimmu.2024.1397485","volume":"15","author":"B Li","year":"2024","unstructured":"Li B, Han Y, Fu Z, Chai Y, Guo X, Du S, Li C, Wang D. The causal relationship between gut microbiota and lymphoma: a two-sample Mendelian randomization study. Front Immunol. 2024;15:1397485.","journal-title":"Front Immunol"},{"key":"734_CR38","doi-asserted-by":"publisher","first-page":"3860896","DOI":"10.1155\/2022\/3860896","volume":"2022","author":"A Sandionigi","year":"2022","unstructured":"Sandionigi A, De Giani A, Tursi F, Michelotti A, Cestone E, Giardina S, Zampolli J, Di Gennaro P. Effectiveness of multistrain probiotic formulation on common infectious disease symptoms and gut microbiota modulation in flu-vaccinated healthy elderly subjects. Biomed Res Int. 2022;2022:3860896.","journal-title":"Biomed Res Int"},{"issue":"2","key":"734_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chom.2016.07.001","volume":"20","author":"M Kim","year":"2016","unstructured":"Kim M, Qie Y, Park J, Kim CH. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe. 2016;20(2):202\u201314.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"734_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4172\/2329-8901.1000159","volume":"5","author":"BP Blackwood","year":"2017","unstructured":"Blackwood BP, Yuan CY, Wood DR, Nicolas JD, Grothaus JS, Hunter CJ. Probiotic lactobacillus species strengthen intestinal barrier function and tight junction integrity in experimental necrotizing enterocolitis. J Probiotics Health. 2017;5(1):159.","journal-title":"J Probiotics Health"},{"issue":"8","key":"734_CR41","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.chom.2022.07.003","volume":"30","author":"H Lu","year":"2022","unstructured":"Lu H, Xu X, Fu D, Gu Y, Fan R, Yi H, He X, Wang C, Ouyang B, Zhao P, et al. Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4\/MyD88\/NF-\u03baB axis. Cell Host Microbe. 2022;30(8):1139\u20131150.e1137.","journal-title":"Cell Host Microbe"},{"issue":"11","key":"734_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260451","volume":"16","author":"M Hirayama","year":"2021","unstructured":"Hirayama M, Nishiwaki H, Hamaguchi T, Ito M, Ueyama J, Maeda T, Kashihara K, Tsuboi Y, Ohno K. Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate. PLoS ONE. 2021;16(11): e0260451.","journal-title":"PLoS ONE"},{"issue":"4","key":"734_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/microorganisms9040697","volume":"9","author":"V Baldelli","year":"2021","unstructured":"Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms. 2021;9(4):697.","journal-title":"Microorganisms"},{"key":"734_CR44","doi-asserted-by":"publisher","first-page":"1015890","DOI":"10.3389\/fcimb.2022.1015890","volume":"12","author":"B Khorsand","year":"2022","unstructured":"Khorsand B, Asadzadeh Aghdaei H, Nazemalhosseini-Mojarad E, Nadalian B, Nadalian B, Houri H. Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn\u2019s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets. Front Cell Infect Microbiol. 2022;12:1015890.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"734_CR45","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/microorganisms9091900","volume":"9","author":"B Krawczyk","year":"2021","unstructured":"Krawczyk B, Wityk P, Ga\u0142\u0119cka M, Michalik M. The many faces of enterococcus spp.-commensal, probiotic and opportunistic pathogen. Microorganisms. 2021;9(9):1900.","journal-title":"Microorganisms"},{"issue":"4","key":"734_CR46","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","volume":"11","author":"M Lopez-Siles","year":"2017","unstructured":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. Isme j. 2017;11(4):841\u201352.","journal-title":"Isme j"},{"issue":"24","key":"734_CR47","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.3390\/nu14245200","volume":"14","author":"JM Bustamante","year":"2022","unstructured":"Bustamante JM, Dawson T, Loeffler C, Marfori Z, Marchesi JR, Mullish BH, Thompson CC, Crandall KA, Rahnavard A, Allegretti JR, et al. Impact of fecal microbiota transplantation on gut bacterial bile acid metabolism in humans. Nutrients. 2022;14(24):5200.","journal-title":"Nutrients"},{"issue":"6","key":"734_CR48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","volume":"178","author":"T Hagan","year":"2019","unstructured":"Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur MS, Das J, Wang H, Guthmiller J, Zheng NY, et al. Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans. Cell. 2019;178(6):1313\u20131328.e1313.","journal-title":"Cell"},{"issue":"4","key":"734_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/imm.12760","volume":"151","author":"JM Larsen","year":"2017","unstructured":"Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151(4):363\u201374.","journal-title":"Immunology"},{"issue":"8","key":"734_CR50","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1158\/0008-5472.CAN-21-4025","volume":"83","author":"AO Yam","year":"2023","unstructured":"Yam AO, Bailey J, Lin F, Jakovija A, Youlten SE, Counoupas C, Gunzer M, Bald T, Woodruff TM, Triccas JA, et al. Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy. Cancer Res. 2023;83(8):1315\u201328.","journal-title":"Cancer Res"},{"issue":"1","key":"734_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29\u201341.","journal-title":"Environ Microbiol"},{"issue":"1","key":"734_CR52","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1038\/s41467-020-17916-9","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ning Z, Mayne J, Yang Y, Deeke SA, Walker K, Farnsworth CL, Stokes MP, Couture JF, Mack D, et al. Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn\u2019s disease. Nat Commun. 2020;11(1):4120.","journal-title":"Nat Commun"},{"issue":"6","key":"734_CR53","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood.2021013990","volume":"140","author":"Z Chen","year":"2022","unstructured":"Chen Z, Simon-Molas H, Cretenet G, Valle-Argos B, Smith LD, Forconi F, Schomakers BV, van Weeghel M, Bryant DJ, van Bruggen JAC, et al. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood. 2022;140(6):630\u201343.","journal-title":"Blood"},{"key":"734_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.885093","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen S, Gui R, Zhou XH, Zhang JH, Jiang HY, Liu HT, Fu YF. Combined microbiome and metabolome analysis reveals a novel interplay between intestinal flora and serum metabolites in lung cancer. Front Cell Infect Microbiol. 2022;12: 885093.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"734_CR55","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/biom11101414","volume":"11","author":"J Gojda","year":"2021","unstructured":"Gojda J, Cahova M. Gut microbiota as the link between elevated BCAA serum levels and insulin resistance. Biomolecules. 2021;11(10):1414.","journal-title":"Biomolecules"},{"issue":"6","key":"734_CR56","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.chom.2023.05.011","volume":"31","author":"K Kasahara","year":"2023","unstructured":"Kasahara K, Kerby RL, Zhang Q, Pradhan M, Mehrabian M, Lusis AJ, Bergstr\u00f6m G, B\u00e4ckhed F, Rey FE. Gut bacterial metabolism contributes to host global purine homeostasis. Cell Host Microbe. 2023;31(6):1038\u20131053.e1010.","journal-title":"Cell Host Microbe"},{"key":"734_CR57","doi-asserted-by":"publisher","first-page":"1338178","DOI":"10.3389\/fimmu.2024.1338178","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang H, Shi G, Zheng X, Chang J, Lin Q, Tian Z, Yang H. The impact of gut microbial signals on hematopoietic stem cells and the bone marrow microenvironment. Front Immunol. 2024;15:1338178.","journal-title":"Front Immunol"},{"issue":"1","key":"734_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1158\/1541-7786.MCR-23-0080","volume":"22","author":"N Hussein","year":"2024","unstructured":"Hussein N, Rajasuriar R, Khan AM, Lim YA, Gan GG. The role of the gut microbiome in hematological cancers. Mol Cancer Res. 2024;22(1):7\u201320.","journal-title":"Mol Cancer Res"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00734-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00734-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00734-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T13:00:22Z","timestamp":1739192422000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00734-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00734-w","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (IRB) (Comitatoetico Catania 1, #CO.TIP. 34\/2020\/PO 0016693 released on April 15th, 2020) and performed according to the principles of the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Our manuscript does not contain any individual person\u2019s data in any form. All patients provided written informed consent according to the procedures described in #CO.TIP. 34\/2020\/PO 0016693 released on April 15th, 2020.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}